Blood Clot Problems from Xeljanz Draw Updated EMA Warning for High Risk Patients
European regulators warn that Xeljanz should not be given to any patients at high risk of blood clots unless absolutely necessary.…
«
»
European regulators warn that Xeljanz should not be given to any patients at high risk of blood clots unless absolutely necessary.…
Side effects of the rheumatoid arthritis and ulcerative colitis drug Xeljanz may result in the development of serious and potentially lethal pulmonary embolism. Lawsuits are being reviewed by lawyers nationwide.…
A new study finds that patients suffering from a pulmonary embolism have a better chance of survival if they go to a busy hospital.…
A new study warns that some melanoma drugs used in combination may increase the risk of serious heart problems.…
The FDA is warning that Pfizer’s ulcerative colitis drug, Xeljanz, could cause pulmonary embolism and deep vein thrombosis at higher doses.…
A new study finds that early placement of IVC filters does not reduce the risk of pulmonary embolism or death in patients who have suffered severe trauma.…
European regulators have placed new restrictions on the use of Xeljanz while they continue to review potential pulmonary embolism risks.…
Xeljanz side effects may increase the risk of pulmonary embolism by a factor of five when taken at higher doses, according to the preliminary findings of a clinical trial.…
Pfizer is suing Ajanta Pharma over plans to release a generic version of Xeljanz years before its patent protection is scheduled to run out.…
Xeljanz side effects can cause pulmonary embolism at high doses, European drug regulators warn.…